Standard 3-dose Schedule

Cecolin 9 is recommended to be administered as three doses of 0.5 mL at 0, 1, and 6 months.

• The second dose should be administered at least 1 month after the first dose.
• The third dose should be administered at least 4 months after the second dose
• All three doses should be given within a 1-year period.

Simplified 2-dose Schedule

Females aged 9–17 years may also receive a 2-dose schedule of 0.5 mL per dose at 0 and 6 months.

• The interval between the two doses should be at least 5 months.

The appropriate dosing schedule should be determined according to the approved product information and individual clinical assessment.

Instructions for vaccination

• Cecolin 9 is injected intramuscularly and the preferred site for vaccination is the deltoid muscle of upper arm.
• Intravascular or intradermal injection is prohibited. There have been no clinical study data on subcutaneous injection of Cecolin 9.
• Cecolin 9 should be shaken well before use and it is a white homogeneous suspension after shaking.
• A separate sterile syringe and needle must be used for each recipient.
• Cecolin 9 should be administered as soon as possible after removal from the refrigeration container.
• Do not use any vial with cracks, an unclear or invalid label, or abnormal vaccine appearance.